Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Bram De Laere

Faculty of Medicine and Health Sciences > Department of Human Structure and Repair

ORCID iD: 0000-0002-1174-0384

Show Sort by

Add to list
- Conference Paper
- C3
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan Vanwelkenhuyzen (UGent) , Mathieu Spaas (UGent) , Kim Van der Eecken (UGent) , Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Lieve Brochez (UGent) , Johan Lindberg, Katleen De Preter (UGent) , Bram De Laere (UGent) and Piet Ost (UGent)

(2022) OncoPoint Symposium 2022, Abstracts.
Add to list
- Journal Article
- A1
- open access
Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma

Annouck Philippron (UGent) , Lieven Depypere, Steffi Oeyen, Bram De Laere (UGent) , Charlotte Vandeputte, Philippe Nafteux, Katleen De Preter (UGent) and Piet Pattyn (UGent)

(2021) PLOS ONE. 16(5).
Add to list
- Journal Article
- A1
- open access
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer

S Oeyen, V Liégeois, Bram De Laere (UGent) , A Buys, M Strijbos, P Dirix, P Meijnders, P Vermeulen, S Van Laere and L Dirix

(2021) PROSTATE CANCER AND PROSTATIC DISEASES. 24(2). p.499-506
Add to list
- Journal Article
- A1
- open access
Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer

Bram De Laere (UGent) , A Crippa, A Mortezavi, C Ghysel, P Rajan, M Eklund, A Wyatt, L Dirix, Piet Ost (UGent) , H Grönberg, et al.

(2021) CANCERS. 13(7).
Add to list
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der Eecken (UGent) , Jan Vanwelkenhuyzen (UGent) , Matthew P. Deek, Phuoc T. Tran, Evan Warner, Alexander W. Wyatt, Edmond M. Kwan, Sofie Verbeke (UGent) , Jo Van Dorpe (UGent) , Valerie Fonteyne (UGent) , et al.

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(6). p.914-923
Add to list
- Conference Paper
- C3
- open access
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der Eecken (UGent) , Maarten Larmuseau (UGent) , Jan Vanwelkenhuyzen (UGent) , Nicolaas Lumen (UGent) , Kathleen Marchal (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Bram De Laere (UGent) and Sofie Verbeke (UGent)

(2021) Global Congress on Prostate and Bladder Cancer 2021, Abstracts.
Add to list
- Journal Article
- A1
- open access
The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Alessio Crippa, Bram De Laere (UGent) , Andrea Discacciati, Berit Larsson, Jason T. Connor, Erin E. Gabriel, Camilla Thellenberg, Elin Janes, Gunilla Enblad, Anders Ullen, et al.

(2020) TRIALS. 21(1).
Add to list
- Conference Paper
- C3
Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan Vanwelkenhuyzen (UGent) , Kim Van der Eecken (UGent) , Bram De Laere (UGent) , Simon Sundling, Rebecka Bergström, Johan Lindberg, Katleen De Preter (UGent) , Henrik Grönberg and Piet Ost (UGent)

(2020) 7th edition of the annual BMUC meeting, Abstracts.